Researchers uncover mechanism of protein GBP1 in immune defense

The protein GBP1 is a vital component of our body’s natural defence against pathogens. This substance fights against bacteria and parasites by enveloping them in a protein coat, but how the substance manages to do this has remained unknown until now.

MHRA approves Pierre Fabre’s vibegron to treat OAB

The asset is indicated for the treatment of overactive bladder syndrome symptoms in adult patients. Credit: New Africa / Shutterstock. The UK Medicines and Healthcare

July 18, 2024

Laser-based 3D bioprinting of corneas for vision restoration

Printing a new cornea during an operation to restore a patient’s eyesight: This groundbreaking step in the fight against corneal disorders is set to become

June 19, 2024

HAIP Chemo Offers OS Advantage in Advanced Intrahepatic Cholangiocarcinoma

SAN FRANCISCO — Hepatic arterial infusion pump (HAIP) chemotherapy with floxuridine significantly improved overall survival (OS) in patients with advanced intrahepatic cholangiocarcinoma (iCCA), according to

January 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.